Adial Pharmaceuticals, Inc (ADIL): Price and Financial Metrics
ADIL Price/Volume Stats
| Current price | $0.57 | 52-week high | $3.00 |
| Prev. close | $0.66 | 52-week low | $0.51 |
| Day low | $0.51 | Volume | 827,683 |
| Day high | $0.69 | Avg. volume | 815,361 |
| 50-day MA | $0.68 | Dividend yield | N/A |
| 200-day MA | $0.89 | Market Cap | 4.52M |
ADIL Stock Price Chart Interactive Chart >
Adial Pharmaceuticals, Inc (ADIL) Company Bio
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic agents for the treatment of alcohol use disorders in the United States. Its lead product is AD04, a selective serotonin-3 antagonist that has completed Phase IIb clinical trials for the treatment of nausea and emesis. The company was founded in 2010 and is based in Charlottesville, Virginia.
ADIL Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ADIL Price Returns
| 1-mo | -12.52% |
| 3-mo | -23.99% |
| 6-mo | -52.50% |
| 1-year | -54.40% |
| 3-year | -98.41% |
| 5-year | -98.67% |
| YTD | -43.56% |
| 2024 | -45.70% |
| 2023 | -65.40% |
| 2022 | -92.04% |
| 2021 | 58.82% |
| 2020 | -29.46% |